Oxyphenonium bromide

CAS No. 50-10-2

Oxyphenonium bromide( Atrenyl | Spasmophen | Oxifenon | Oxyfenon | Oxyphenon )

Catalog No. M28007 CAS No. 50-10-2

Oxyphenonium bromide shows anticholinergic activity and can be used for research on the treatment of gastric and duodenal ulcers and for the relief of visceral spasms.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 35 Get Quote
25MG 56 Get Quote
50MG 82 Get Quote
100MG 120 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Oxyphenonium bromide
  • Note
    Research use only, not for human use.
  • Brief Description
    Oxyphenonium bromide shows anticholinergic activity and can be used for research on the treatment of gastric and duodenal ulcers and for the relief of visceral spasms.
  • Description
    Oxyphenonium bromide shows anticholinergic activity and can be used for research on the treatment of gastric and duodenal ulcers and for the relief of visceral spasms.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Atrenyl | Spasmophen | Oxifenon | Oxyfenon | Oxyphenon
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    HIV
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    50-10-2
  • Formula Weight
    428.411
  • Molecular Formula
    C21H34BrNO3
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?H2O : 125 mg/mL (291.78 mM)
  • SMILES
    [Br-].CC[N+](C)(CC)CCOC(=O)C(O)(C1CCCCC1)c1ccccc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Victor Van Puyenbroeck, et al. Preprotein signature for full susceptibility to the co-translational translocation inhibitor cyclotriazadisulfonamide. Traffic. 2020 Feb;21(2):250-264.
molnova catalog
related products
  • AD 01

    FKBPL (FK506-binding protein like)-based peptide. Binds to and upregulates expression of CD44. Inhibits breast cancer stem cell (BCSC) growth. Decreases pluripotency markers and promotes differentiation of BCSCs. Also inhibits endothelial cell migration as well as tubule and microvessel formation in vitro and in vivo. Blocks tumor growth in xenograft models.

  • Glucosyringic acid

    Glucosyringic acid has immunosuppressive effect, it can inhibit the proliferation of murine B lymphocytes in vitro.

  • Etidocaine

    Etidocaine is an amino acidamide that acts as a local anesthetic with fast onset and long-acting properties.